Basic Information

Reference Number

WS5477634525-Doc5477646953

Issuing Organization

Department of Public Works and Government Services (PSPC)

Owner Organization

Public Health Agency of Canada (PHAC)

Solicitation Type

ACAN - Advance Contract Award Notice (Formal)

Solicitation Number

WS5477634525

Title

ACAN-Smallpox antiviral

Source ID

PWGSC

Agreement Types

Canada-Chile Free Trade Agreement (CCFTA)

Canada-Colombia Free Trade Agreement

Canada-European Union Comprehensive Economic and Trade Agreement(CETA)

Canada-Honduras Free Trade Agreement

Canada-Korea Free Trade Agreement

Canada-Panama Free Trade Agreement

Canada-Peru Free Trade Agreement (CPFTA)

Canadian Free Trade Agreement (CFTA)

Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)

World Trade Organization Agreement on Government Procurement (WTO-AGP)

Canada-Ukraine Free Trade Agreement (CUFTA)

Canada-UK Trade Continuity Agreement (Canada-UK TCA)

Details

Location

National Capital Region

Dates

Publication

2025/12/17 12:00:00 AM EST

Closing Date

2026/01/16 02:00:00 PM EST

Contact Information

Ramenason, Anja (SPAC/PSPC)

anja.ramenason@tpsgc-pwgsc.gc.ca

Description

Advanced Contract Award Notice - Smallpox antiviral
An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier.
Purpose of this ACAN:
Public Services and Procurement Canada proposes to negotiate a contract with Emergent Biodefense Operations Lansing LLC. on behalf of the Public Health Agency of Canada (PHAC) for the purchase of Tembexa® (brincidofovir) which is an antiviral used to treat smallpox.
Limited Tendering Reason:
In accordance with Government Contract Regulations (GCRs Part 1 - Conditions of Contract Entry - Bids - 6.(d)) Emergent Biodefense Operations Lansing LLC., is the only known supplier capable of providing an antiviral that is a nucleotide analog DNA polymerase inhibitor and also for treatment of smallpox in pediatric patients.

Disclaimer Government of Canada (GC) tender notices and awards, solicitation documents and tender attachments are available free of charge and without registration on canadabuys.canada.ca/en/tender-opportunities, the authoritative location for GC tenders.

You may have received this tender notice or award through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly through canadabuys.canada.ca/en/tender-opportunities.

This Government of Canada tender notice or tender award carries an Open Government Licence - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to the section about Commercial Reproduction in the canadabuys.canada.ca/en Terms and Conditions for more information.

Contains information licensed under the Open Government license - Canada. Contains data reproduced and distributed with the permission of the Government of Canada, on an "as is" basis.